1. Home
  2. RGS vs AIDX Comparison

RGS vs AIDX Comparison

Compare RGS & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$21.31

Market Cap

53.3M

ML Signal

N/A

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$2.45

Market Cap

58.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGS
AIDX
Founded
1922
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.3M
58.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
RGS
AIDX
Price
$21.31
$2.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.7K
318.0K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
20.24
N/A
EPS
0.64
N/A
Revenue
$210,134,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.81
N/A
Revenue Growth
3.52
N/A
52 Week Low
$15.00
$2.42
52 Week High
$31.50
$14.09

Technical Indicators

Market Signals
Indicator
RGS
AIDX
Relative Strength Index (RSI) 40.27 4.83
Support Level $18.63 N/A
Resistance Level $23.67 $3.08
Average True Range (ATR) 0.86 1.23
MACD -0.06 -0.25
Stochastic Oscillator 44.27 0.51

Price Performance

Historical Comparison
RGS
AIDX

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: